Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)

NCT00725751 · clinicaltrials.gov ↗

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: Pegylated interferon alfa-2b (PegIFN-2b)
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC